Literature DB >> 476618

Influence of immune status on the metastasis of three murine fibrosarcomas of different immunogenicities.

I J Fidler, D M Gersten, M L Kripke.   

Abstract

Three fibrosarcomas of different immunogenicities were tested for their ability to form spontaneous and experimentally induced metastases in normal, sham-suppressed, immunosuppressed, and immunologically restored syngeneic mice. Immunosuppression, achieved by adult thymectomy and sublethal X-irradiation (450 R), affected experimental metastasis of the three tumors in different ways. Upon i.v. injection, the highly immunogenic fibrosarcoma formed more pulmonary tumor colonies in immunosuppressed mice than in normal, sham-suppressed (sham thymectomy and 450 R), or immunologically reconstituted animals (thymectomy, X-irradiation, plus 10(7) normal syngeneic lymphocytes given i.v.). A fibrosarcoma of intermediate immunogenicity also formed more pulmonary metastases in immunosuppressed recipients, but this increase could not be reversed by reconstitution with 10(7) lymphocytes. In contrast, the least immunogenic tumor formed fewer pulmonary tumor colonies in immunosuppressed mice than in normal, sham-suppressed, or immunologically reconstituted mice. We conclude that the role of the immune system in experimental cancer metastasis varies for different tumors and that tumor immunogenicity is an important factor in the relationship between host immunity and tumor dissemination.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 476618

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

Review 1.  AACR centennial series: the biology of cancer metastasis: historical perspective.

Authors:  James E Talmadge; Isaiah J Fidler
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

2.  Antigenicity of UV radiation-induced murine tumors correlates positively with the level of adenosine deaminase activity.

Authors:  S L Aukerman; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

Review 3.  Review: biologic heterogeneity of cancer metastases.

Authors:  I J Fidler
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

4.  Tumor progression, oncogenes and the evolution of metastatic phenotypic diversity.

Authors:  G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1984 Apr-Jun       Impact factor: 5.150

5.  Antigenic variation in cancer metastasis: immune escape versus immune control.

Authors:  V Schirrmacher; M Fogel; E Russmann; K Bosslet; P Altevogt; L Beck
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

Review 6.  Proteases in the schistosome life cycle: a paradigm for tumour metastasis.

Authors:  M J Doenhoff; R H Curtis; J Ngaiza; J Modha
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

Review 7.  Generation of phenotypic diversity and progression in metastatic tumor cells.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

Review 8.  Immunology of metastasis. Can the immune response cope with disseminated tumor?

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

9.  Heterogeneity of isozyme expression in tumor cells does not correlate with metastatic potential.

Authors:  S L Aukerman; M J Siciliano; I J Fidler
Journal:  Clin Exp Metastasis       Date:  1986 Jul-Sep       Impact factor: 5.150

Review 10.  Inhibition of the arrest of hematogenously disseminated tumor cells.

Authors:  E Tsubura; T Yamashita; S Sone
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.